Utama › Leukemia Mieloid Kronik
Kajian klinikal Leukemia Mieloid Kronik sedang mengambil peserta di AS
48 kajian untuk Leukemia Mieloid Kronik sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX18 kajian
- Seattle, WA11 kajian
- New York City, NY11 kajian
- Detroit, MI6 kajian
- Birmingham, AL6 kajian
- Philadelphia, PA6 kajian
- Chicago, IL6 kajian
- Baldwin Park, CA6 kajian
- Portland, OR6 kajian
- Nashville, TN5 kajian
- Columbus, OH5 kajian
- Milwaukee, WI5 kajian
- Baltimore, MD5 kajian
- Atlanta, GA5 kajian
- Boston, MA5 kajian
- Durham, NC5 kajian
- Rochester, NY4 kajian
- Mountain View, CA4 kajian
- Cincinnati, OH4 kajian
- Kansas City, MO4 kajian
- Augusta, GA4 kajian
- Washington, DC4 kajian
- St. Louis, MO4 kajian
- Sacramento, CA3 kajian
- Edison, NJ3 kajian
- Salt Lake City, UT3 kajian
- Cleveland, OH3 kajian
- Orange, CA3 kajian
- Miami, FL3 kajian
- Bridgeport, CT3 kajian
- Buffalo, NY3 kajian
- Ann Arbor, MI3 kajian
- Aurora, CO3 kajian
- St. Petersburg, FL3 kajian
- Greenville, NC3 kajian
- Minneapolis, MN3 kajian
Mengikut negeri
- Alabama6 kajian
- Arizona4 kajian
- California10 kajian
- Colorado4 kajian
- Florida7 kajian
- Georgia7 kajian
- Illinois6 kajian
- Indiana3 kajian
- Kansas5 kajian
- Kentucky3 kajian
- Maryland6 kajian
- Massachusetts5 kajian
- Michigan7 kajian
- Minnesota4 kajian
- Missouri4 kajian
- Nebraska3 kajian
- New Jersey4 kajian
- New York15 kajian
- North Carolina8 kajian
- Ohio9 kajian
- Oregon6 kajian
- Pennsylvania7 kajian
- Tennessee5 kajian
- Texas18 kajian
- Utah3 kajian
- Virginia4 kajian
- Washington11 kajian
- Wilayah Columbia3 kajian
- Wisconsin5 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Mengambil pesertaFasa 1
Umur 18 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06904066Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Mengambil pesertaKajian pemerhatian
Umur 0 hingga 38 · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06131801Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06817720Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
Mengambil pesertaFasa 1/2
Umur 1 hingga 17 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT04925479Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07269470Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06236724Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Mengambil pesertaFasa awal 1
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06398457Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
Mengambil pesertaFasa 1
Umur 1 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT03630991Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT01746836Study of Olverembatinib (HQP1351) in Patients With CML-CP
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06423911Cord Blood Transplant in Adults With Blood Cancers
Mengambil pesertaFasa 2
Umur 21 hingga 65 · Semua jantina · Dikemas kini 11 Sep 2026 · NCT05884333Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Mengambil pesertaFasa 2
Umur 1 hingga 18 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT07354074Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Ogo 2026 · NCT06523556Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Mengambil pesertaFasa 1
1 Day – 21 Years · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT05857969Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT04838041TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Mengambil pesertaFasa 1
Umur 18 hingga 80 · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT07302776Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
Mengambil pesertaFasa 2
6 Months – 65 Years · Semua jantina · Dikemas kini 22 Jul 2026 · NCT06013423A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 6 Jul 2026 · NCT01351545Allo HSCT Using RIC and PTCy for Hematological Diseases
Mengambil pesertaFasa 2
Sehingga umur 75 · Semua jantina · Dikemas kini 6 Jul 2026 · NCT05805605Asciminib Roll-over Study
Mengambil pesertaFasa 4
Umur 7 hingga 100 · Semua jantina · Dikemas kini 6 Jul 2026 · NCT04877522Registry of Older Patients With Cancer
Mengambil pesertaKajian pemerhatian
Umur 65 ke atas · Semua jantina · Dikemas kini 29 Jun 2026 · NCT01137825Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Mengambil pesertaFasa 2
Sehingga umur 60 · Semua jantina · Dikemas kini 25 Jun 2026 · NCT03314974Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jun 2026 · NCT05549661Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Jun 2026 · NCT07638007Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.